Unlock instant, AI-driven research and patent intelligence for your innovation.

Liquid vaccines of live enveloped viruses

A liquid vaccine, enveloped virus technology, applied in the field of vaccinology, can solve the problem of no public vaccine, no quantitative data on the long-term stability of virus infectivity, etc., to achieve the effect of saving time and cost

Pending Publication Date: 2020-08-07
INTERVET INT BV
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite its RNA genome, as a plant virus, TMV has no envelope
In addition, the paper does not disclose a vaccine, nor does it provide quantitative data on the long-term stability of the virus's infectivity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liquid vaccines of live enveloped viruses
  • Liquid vaccines of live enveloped viruses
  • Liquid vaccines of live enveloped viruses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0171] Example 1: Methods and Materials

[0172] 1.1 Preparation of NADES preparation

[0173] NADES can be prepared by mixing, which can be accelerated by heating and / or adding a small amount of water. Some of the NADES samples tested and described further below in this application were prepared by dissolving organic salts and polyols in excess water. Next, excess water was removed by rotary evaporation in a 70 °C water bath for several hours at reduced atmospheric pressure. By taking into account the weight loss due to evaporation, the amount of water present in NADES can be calculated.

[0174] Other NADES samples were prepared by sonication in a water bath. Add the required amount of powder to the flask. Shake or vortex the flask briefly to mix the powder. Next, add the desired amount of water. The mixture was placed in a sonication-water bath set at 45°C and sonicated for several hours until NADES formed. During sonication, the maximum temperature can reach up t...

Embodiment 2

[0207] Example 2: Examples of NADES used in the present invention

[0208] A number of NADES formulations were prepared for use in the present invention with different compounds, different molar ratios and different water contents.

[0209] Some of the most effective NADES formulations are listed in Table 1 below; these produced clear liquid solutions that were fluid at room temperature (20-25°C). Detailed information on its composition and water content is provided. For several samples prepared, water activity was determined and the results are included. Where not indicated: the molecular weight of water is 18 Da; the trehalose used is dihydrate.

[0210] The following conclusions can be drawn:

[0211] - Choline, betaine and proline are the most versatile and effective organic acids for use in the present invention, and sorbitol, glycerol and xylitol are the most effective polyols.

[0212] - NADES can be easily prepared with water content up to 37% w / v, resulting in l...

Embodiment 3

[0218] Embodiment 3: virus stability determination result

[0219] As described above, extended stability assays were carried out for various enveloped viruses comprised in the liquid vaccine compositions according to the invention. These assays were performed at the following 3 temperatures: 4, 14 and 25°C.

[0220] Incubation for 8 weeks at 25°C can be used as an accelerated stability test, indicating the effect of incubation for 1-2 years at 4°C. Therefore, this is a very serious attack on the stability of the virus, and not all samples can be expected to survive for such a long time under these conditions.

[0221] Table 2: Stability results of BRSV and PI3 viruses

[0222]

[0223] Table 3: Stability results of CPiV

[0224]

[0225] Some conclusions from the stability results

[0226] In particular CPiV viruses were very well stabilized by the NADES 3 (stab.3) formulation; even after 8 weeks at 25°C, most of the viruses were still infectious.

[0227] Simi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Viscosityaaaaaaaaaa
Viscosityaaaaaaaaaa
Viscosityaaaaaaaaaa
Login to View More

Abstract

The present invention describes a liquid vaccine composition of a live enveloped virus and a pharmaceutically acceptable carrier, whereby the carrier is a natural deep-eutectic solvent (NADES), and the vaccine has a water activity of less than about 0.8. The NADES provides a stabilisation of the sensitive virus for prolonged time and at ambient temperature. In general, the liquid vaccine compositions according to the invention, in different compositions for the various enveloped viruses, show remarkable capabilities of stabilisation. This overcomes the need for lyophilisation, a great economicbenefit. Also the liquid nature of the vaccines facilitates administration to human or animal targets.

Description

technical field [0001] The present invention relates to the field of vaccinology. In particular, the invention relates to liquid vaccine compositions of live enveloped viruses. Furthermore, the present invention relates to methods for the preparation of such compositions and their use in medicine, to kits and to the use of NADES. Background technique [0002] Deep eutectic solvents (DES) are well known compositions with many remarkable properties. Typically, these are mixtures of compounds that are liquid at ambient temperature but have a low water content. Also, the small amount of water present is tightly bound, limiting its availability in chemical or biological processes. This is indicated by very low water activity values. For example, Abbott et al., 2003, Chem. Commun., vol.1, p.70-71 and in WO 2009 / 120839 describe DES. [0003] DES is also known as "protic ionic liquid". Its predecessor was an "ionic liquid" consisting of only one molten salt, which has long bee...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/12C07K14/005A61P31/14
CPCA61K39/12C07K14/005A61P31/14Y02A50/30A61K9/08A61K39/155A61K39/175A61K39/215A61K39/245A61K47/10A61K47/186A61K47/22A61K47/26A61K2039/525A61K2039/54A61K2039/543C12N7/00C12N2710/16034C12N2760/00034C12N2760/18034C12N2760/18434C12N2760/18634C12N2770/20034
Inventor P·维尔梅吉E·凯特斯C·德克斯M·皮埃斯特
Owner INTERVET INT BV